Ideas to Action:

Independent research for global prosperity

Global Health Policy

CGD experts discuss such issues as health financing, drug resistance, clinical trials, vaccine development, HIV/AIDS, and health-related foreign assistance.

X

Global Health Policy

Feed

 

Will Obama Follow UK Meeting with Adequate Money for Vaccines?

6/9/11
Owen Barder

One result of President Obama’s visit to the UK last month was a statement on the UK-US Partnership for Global Development in which the U.S. President and Prime Minister David Cameron “reaffirm [their] commitment to changing the lives of 1.2 billion poor people in the world today." In the statement they promise to work together on a range of important development issues: economic growth, conflict and fragile states, aid (accountability, transparency, results), global health, girls and women, and climate change.

2 comments

Break Out the Champagne! The AMC Delivers Vaccines

12/13/10
Owen Barder

This weekend, children in Nicaragua received Advance Market Commitment (AMC)-financed pneumococcal vaccines that protect against the strains of pneumonia, meningitis and sepsis common in poor countries. Thanks in part to the AMC, the new and improved pneumo vaccines will reach the world's poorest children during the same year children in wealthy countries obtained access, and at a fraction of the price.

1 comment

Insuring the Flu: Vaccines for All?

6/29/07
Ruth Levine

Reuters recently reported that the global health community is beginning to explore potential insurance mechanisms and risk management products to finance pandemic flu vaccines for developing countries, in addition to a new vaccine stockpile supported by GSK and other manufacturers:

1 comment

The End of Cervical Cancer?

5/25/06

Late last week, the Vaccine and Related Biological Products advisory committee at the Food and Drug Administration (FDA) unanimously endorsed the petition for Merck’s forthcoming vaccine against human papillomavirus (HPV), a sexually transmitted disease that causes cervical cancer. The final decision from the FDA is expected on June 8 (see article in the Washington Post).

1 comment

Pages

Tags

Experts

By Date